☰

Scott R. Vandenberg, MD, PhD

Affiliations: 
Pathology University of California, San Diego, La Jolla, CA 
Google:
"Scott Vandenberg"
Bio:

UNIVERSITY CALIFORNIA SAN DIEGO
PATHOLOGY DEPARTMENT
9500 GILMAN DRIVE #0612
LA JOLLA, CA 92093
United States

Mean distance: 18.22 (cluster 24)
 
Cross-listing: Neuropathology Tree

Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee
Karra A Jones post-doc 2012-2014 UCSD

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Rajaram S, Roth MA, Malato J, et al. (2019) A multi-modal data resource for investigating topographic heterogeneity in patient-derived xenograft tumors. Scientific Data. 6: 253
Wang J, Merino DM, Light N, et al. (2019) Myc and loss of p53 cooperate to drive formation of choroid plexus carcinoma. Cancer Research
Campbell MJ, Yau C, Bolen J, et al. (2019) Abstract CT003: Analysis of immune cell infiltrates as predictors of response to the checkpoint inhibitor pembrolizumab in the neoadjuvant I-SPY 2 TRIAL Cancer Research. 79
Atreya CE, Ruiz-Saenz A, Wang C, et al. (2019) Abstract B023: A reversible SRC-relayed COX2-inflammatory program drives therapeutic resistance in BRAF(V600E) colorectal tumors Molecular Cancer Therapeutics. 18
Campbell M, Yau C, Borowsky A, et al. (2018) Abstract PD6-08: Analysis of immune infiltrates (assessed via multiplex fluorescence immunohistochemistry) and immune gene expression signatures as predictors of response to the checkpoint inhibitor pembrolizumab in the neoadjuvant I-SPY 2 trial Cancer Research. 78
Li J, Taich ZJ, Akers J, et al. (2016) Abstract 4459: Altered signal transduction in Isocitrate Dehydrogenase (IDH) mutated glioblastomas and implication on precision medicine Cancer Research. 76: 4459-4459
Jones KA, Gilder AS, Lam MS, et al. (2015) Selective coexpression of VEGF receptor 2 in EGFRvIII-positive glioblastoma cells prevents cellular senescence and contributes to their aggressive nature. Neuro-Oncology
Kozono D, Li J, Nitta M, et al. (2015) Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression. Proceedings of the National Academy of Sciences of the United States of America. 112: E4055-64
Wykosky J, Hu J, Gomez GG, et al. (2015) A urokinase receptor-Bim signaling axis emerges during EGFR inhibitor resistance in mutant EGFR glioblastoma. Cancer Research. 75: 394-404
Chen C, Kozono D, Li J, et al. (2015) Abstract PR02: Dynamic epigenetic regulation of glioblastoma tumorigenicity through a LSD1-MYC-OLIG2 axis Molecular Cancer Research. 13
See more...